Oxaliplatin Hikma 5 mg/ml Konzentrat zur Herstellung einer Infusionslösung

Recall | Medicines | 21/08/2024

The marketing authorization holder informed its customers on August 15, 2024, that glass breakage may occur at the neck of the vial when the crimp cap is removed. For this reason, the mentioned batch is being recalled as a precautionary measure.

Name of the medicinal product Oxaliplatin Hikma 5 mg/ml Konzentrat zur Herstellung einer Infusionslösung
Marketing authorisation number(s) 141043
CIP code 5508424
Marketing authorisation holder Hikma Farmaceutica (Portugal) S.A.
Batch number(s) 241073
Expiry date 02/28/2026
Classification of the recall2
Depth of recall Pharmacies
BASG reference number INS-640.001-4879
Email

Further inquiry note